Rhythm

AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch

The two leading innovative companies have announced a landmark agreement to equip Mawi’s new cardiac monitoring watch with AccurKardia’s automated ECG analytics NEW YORK & LONDON–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced today it will collaborate with Mawi, a medtech provider of medical […]

RhythMedix® Expands Monitoring Capabilities of Its RhythmStar® System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

Strategic addition of Extended Wear Holter monitoring modality enhances portfolio offering and positions company for accelerated growth MOUNT LAUREL, N.J., Oct. 18, 2022 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms, today announced expanded modalities for its RhythmStar® System (RhythmStar). The addition of long-term continuous electrocardiogram (ECG) monitoring […]

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced submission of pivotal clinical data from the AcQForce Flutter trial designed to gain marketing approval from […]

Medtronic first to receive FDA approval for pacing the heart’s natural conduction system

Medtronic “conduction system pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates DUBLIN, Oct. 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for […]

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

The HELIOSTAR™ Balloon Ablation Catheter’s unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution1 IRVINE, Calif., Oct. 13, 2022 /PRNewswire/ — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation […]

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress Westport, CT, Oct. 12, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with […]

SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Artificial Intelligence Technology Designed to Determine Heart Failure Stage Using Electrocardiogram Data

University of Tokyo Hospital collaborated on development of the technology designed to reduce the burden on medical staff performing heart failure staging TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for technology designed to use artificial intelligence (AI) to stage heart failure. Patent US […]

AccurKardia’s ‘AccurBeat’ Found to be Promising Alternative in QT/QTc Remote Monitoring According to Study by HITLAB and SUNY Downstate

New study published on JMIR Formative Research showcases clinical performance of AccurKardia’s AccurBeat platform for QT/QTc remote monitoring using smartwatch ECG data NEW YORK–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the clinical value of its AccurBeat platform. […]

New Data Demonstrates Vektor Medical’s vMap® Reduces Procedural Duration, Fluoroscopy Use, and Cost

Positive efficiency results presented at American College of Physicians Southern California Chapters 1, 2, 3 Poster Competition and Scientific Program SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, announced study results that demonstrate a significant reduction in […]

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

Leading medical center in San Antonio acquires BioSig’s novel digital signal processing technology for arrhythmia care Westport, CT, Oct. 07, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary […]